Spruce Point Capital Management Announces Investment Opinion: Releases Report and Strong Sell Research Opinion on iRhythm Technologies (NASDAQ: IRTC) - Candlesense
IRTC Research

Spruce Point Capital Management Announces Investment Opinion: Releases Report and Strong Sell Research Opinion on iRhythm Technologies (NASDAQ: IRTC)

NEW YORK--(BUSINESS WIRE)--Spruce Point Capital Management, LLC (“Spruce Point” or “we” or “us”), a New York-based investment management firm that focuses on forensic research and short-selling, today issued a detailed report entitled “Investor Complacency is Off the Charts” that outlines why we believe and estimate that shares of iRhythm Technologies, Inc. (Nasdaq: IRTC) (“iRhythm” or the “Company”) face up to 40% – 70% potential long-term downside to approximately $43 - $94 per share, represe

Related Questions

How likely is Spruce Point’s 40‑70% downside target to be realized and what catalysts could trigger it? What specific risks or red flags did Spruce Point identify that could materially impact iRhythm’s business model and financials? How might this strong sell opinion affect short interest, options pricing, and overall market sentiment toward IRTC?
Find similar articles on Candlesense businesswire